… essential hypertension, the antihypertensive efficacy of nicardipine has been maintained for
periods of up to 1 year. Nicardipine monotherapy decreased mean arterial … , indicating its …

… The inclusion criteria for selection of studies for analysis were evaluation of antihypertensive
therapy in patients with mild or moderate essential hypertension (SBP 140–179mm Hg and/…

… Adult male and female patients, aged 18 to 70 years, with moderate-to-severe essential
hypertension who gave written informed consent were included into the study if their average …

… severe arterial hypertension (grade 3, eg, BP ≥180/110 mm Hg), type 1 diabetes, or secondary
arterial hypertension … to the standardized protocol at the hypertension unit of the hospital. …

… to be crucial since the majority of hypertensive patients need life-long treatment. Fixed low
dose combination therapy controls hypertension without compromising efficacy, safety or …

… meta-analysis, we sought to clarify the efficacy of β-blockers for primary hypertension with
… , MI or death) relevant to hypertension patients and their physicians. Most importantly, we …

… arterial blood pressure (10 to 14%), systolic blood pressure (10 to 14%), diastolic blood
pressure (6 to 17%) and systemic vascular resistance (14 to 27%) were seen in hypertensive …

… The present study was conducted to examine the efficacy and tolerability of moxonidine
in patients with essential hypertension (World Health Organization stages I and II). The …

… ability of various antihypertensive agents to reduce left ventricular hypertrophy, a strong,
blood pressure—independent cardiovascular risk factor, in persons with essential hypertension. …

… Nebivolol (5 mg) is indicated for the treatment of essential hypertension and, in elderly
patients ≥70 years, for the treatment of stable mild and moderate chronic heart failure in addition …